Predicting Physical Features and Diseases by DNA Analysis: Current Advances and Future Challenges
; Ramallo, Virginia
; Hünemeier, Tábita ; de Azevedo, Soledad
; Quinto Sanchez, Mirsha Emmanuel
; Paschetta, Carolina Andrea
; Cintas, Celia
; González, Marina Fernanda
; Schüler-faccini, Lavinia ; Bortolini, María Cátira ; González José, Rolando 
Otros responsables
Fecha
08/2016
Editorial
OMICS International
Revista
Journal of Forensic Research
Título del libro
Nombre del evento
Fecha del evento
Institución organizadora
ISSN
2157-7145
eISSN
ISBN
Idioma
Inglés
Tipo del evento
Clasificación temática
Resumen
The 'omics' era and its concomitant technological advances have brought great insight into genetics. One of the most promising fields within human genetics is the prediction of physical traits from analysis of genetic material. Besides the predictive potential of DNA, the traceability of pathogenic agents in the human body through molecular analysis is also a field to be further exploited. In this review, we aim to discuss specific aspects of phenotypic prediction by analysing DNA, with special emphasis on normal variation, and the application of a technology known as ‘Forensic DNA Phenotyping’ (FDP). We also suggest the term ‘Phenotype Informative Markers’ (PIMs) to designate any molecular markers responsible for normal or pathological human phenotypic variation. In addition, we raise some recommendations related to forensic genetics, the molecular diagnosis of human diseases, and the traceability of pathogens in the human body, giving special emphasis to the need for validation of these tests with strict protocols. Some relevant concerns about privacy, ethics, and legality of such predictions have also been discussed. Finally, we look at perspectives on the use of epigenetic tools, and quote some examples of what has been done in this specific field.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
